Last reviewed · How we verify
intrathecal baclofen
intrathecal baclofen is a Small molecule drug developed by MedtronicNeuro. It is currently FDA-approved.
Intrathecal baclofen is a small molecule that acts as a GABA-B receptor agonist, used to treat conditions such as spasticity. It is administered via an intrathecal pump, which delivers the medication directly to the spinal cord.
At a glance
| Generic name | intrathecal baclofen |
|---|---|
| Sponsor | MedtronicNeuro |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intrathecal Baclofen and Pediatric Dystonia (NA)
- A Prospective Cohort Study of ITB Treatment for HSP
- Predictive Factors for Succes of ITB in CP
- "Epidural Spinal Cord Stimulation: Addressing Spasticity and Motor Function" (NA)
- Intrathecal (IT) Baclofen Drug Distribution (PHASE4)
- Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) (NA)
- Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP). Preliminary Study. (NA)
- Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intrathecal baclofen CI brief — competitive landscape report
- intrathecal baclofen updates RSS · CI watch RSS
- MedtronicNeuro portfolio CI
Frequently asked questions about intrathecal baclofen
What is intrathecal baclofen?
Who makes intrathecal baclofen?
What development phase is intrathecal baclofen in?
Related
- Manufacturer: MedtronicNeuro — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing